Featured Publications
Pharmacological and non-pharmacological interventions to prevent delirium in critically ill patients: a systematic review and network meta-analysis
Burry LD, Cheng W, Williamson DR, Adhikari NK, Egerod I, Kanji S, Martin CM, Hutton B, Rose L. Pharmacological and non-pharmacological interventions to prevent delirium in critically ill patients: a systematic review and network meta-analysis. Intensive Care Medicine 2021, 47: 943-960. PMID: 34379152, PMCID: PMC8356549, DOI: 10.1007/s00134-021-06490-3.Peer-Reviewed Original ResearchConceptsNon-pharmacological interventionsDelirium occurrenceIll adultsIll patientsInternational Clinical Trials RegistryDuration of deliriumOccurrence of deliriumMechanical ventilation durationMulti-component non-pharmacological interventionsClinical Trials RegistryLength of stayMulti-component interventionRandom-effects modelingEvidence networksWeb of ScienceEvidence certaintySedation interruptionSedative interruptionHospital lengthICU lengthCochrane riskSecondary outcomesStandard careBias toolControlled Trials
2022
Humoral and Cellular Response of Transplant Recipients to a Third Dose of mRNA SARS-CoV-2 Vaccine: A Systematic Review and Meta-analysis
Bailey A, Maganti H, Cheng W, Shorr R, Buchan C, Allan D. Humoral and Cellular Response of Transplant Recipients to a Third Dose of mRNA SARS-CoV-2 Vaccine: A Systematic Review and Meta-analysis. Transplantation 2022, 107: 204-215. PMID: 36398334, PMCID: PMC9746229, DOI: 10.1097/tp.0000000000004386.Peer-Reviewed Original ResearchConceptsMRNA SARS-CoV-2 vaccineSARS-CoV-2 vaccinesTransplant recipientsThird doseSystematic reviewMeta-analysisNational Institutes of Health Quality Assessment ToolCochrane risk of bias toolAssociated with reduced oddsRisk of bias toolDose of mRNA SARS-CoV-2 vaccineMeta-Analysis reporting guidelinesQuality assessment toolHumoral responseSARS-CoV-2 mRNA vaccinesPreferred Reporting ItemsDerSimonian-Laird random-effects modelRandomized controlled trialsAdult transplant recipientsRandom-effects modelLack of controlled studiesClinically relevant thresholdsResponse to vaccinationCochrane riskReporting Items
2019
Pharmacologic and surgical therapies for patients with Meniere’s disease: a protocol for a systematic review and meta-analysis
Ahmadzai N, Cheng W, Wolfe D, Bonaparte J, Schramm D, Fitzpatrick E, Lin V, Skidmore B, Esmaeilisaraji L, Kilty S, Hutton B. Pharmacologic and surgical therapies for patients with Meniere’s disease: a protocol for a systematic review and meta-analysis. Systematic Reviews 2019, 8: 341. PMID: 31888735, PMCID: PMC6937806, DOI: 10.1186/s13643-019-1195-1.Peer-Reviewed Original ResearchConceptsSensorineural hearing lossMeniere's diseaseQuality of lifeSystematic reviewHearing-related disabilitySeverity of vertigoAttacks of vertigoIntractable Meniere's diseaseKey clinical trialsIntensity of tinnitusPre-specified eligibility criteriaCause of disabilityClinical treatment strategiesPlanned systematic reviewElectronic search strategyOptimal clinical treatment strategiesMedical information specialistBackgroundHearing lossVertigo attacksCochrane riskSurgical therapyBias toolSurgical interventionCochrane LibraryFuture trials
2018
A protocol for a network meta-analysis of interventions to treat patients with sudden sensorineural hearing loss
Ahmadzai N, Kilty S, Wolfe D, Bonaparte J, Schramm D, Fitzpatrick E, Lin V, Cheng W, Skidmore B, Moher D, Hutton B. A protocol for a network meta-analysis of interventions to treat patients with sudden sensorineural hearing loss. Systematic Reviews 2018, 7: 74. PMID: 29769117, PMCID: PMC5956787, DOI: 10.1186/s13643-018-0736-3.Peer-Reviewed Original ResearchConceptsSudden sensorineural hearing lossIdiopathic sudden sensorineural hearing lossSensorineural hearing lossQuality of lifeHearing lossSystematic reviewExperienced medical information specialistPoor functional statusClinical Trials RegistryPre-specified eligibility criteriaIncidence of harmsCause of disabilityMeasurable hearing lossRisk of anxietyClinical treatment strategiesPlanned systematic reviewOptimal clinical treatment strategiesMajority of casesMedical information specialistBackgroundHearing lossCochrane riskHearing recoveryBias toolTrials RegistryTherapeutic options